October 12, 2021
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
READ MORE >
Sophisticated formulations in every stage of development from MOLECULE to FORMULATION to CLINICAL 
Our Technologies
EMULSOL
AMORSOL
NANOSOL
A wide array of pharmaceutical development capabilities for manufacturing and
analyzing drug product dosage forms. READ MORE >
FEATURED
Ascendia Solidifies Leading CDMO Position By Ranking on Inc. 5000 List Again
Ascendia Pharmaceuticals solidified its position as a leading pharmaceutical contract formulation development and manufacturing organization (CDMO) by once again being […]
READ MOREPARTNERING WITH ASCENDIA
Ascendia provides its partners rapid, comprehensive and cost-effective
solutions for their difficult formulation development projects. LEARN MORE >
ASCENDIA NEWSROOM
October 7, 2021
Ascendia Pharmaceuticals, one of the fastest-growing contract development and manufacturing organizations (CDMOs), will exhibit at AAPS PharmSci360 in Philadelphia, October […]
READ MORE >September 13, 2021
Pharmaceutical companies continue to develop nano-formulations for poorly water-soluble drugs because of their proven effectiveness in commercial products. When considering […]
READ MORE >